Crinone

Crinone

progesterone

Manufacturer:

Merck

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Progesterone
Indications/Uses
Disorders associated w/ progesterone deficiency eg, infertility due to inadequate luteal phase; for use during IVF, where infertility is mainly due to tubal, idiopathic or endometriosis-linked sterility associated w/ normal ovulatory cycles.
Dosage/Direction for Use
Infertility due to inadequate luteal phase 1 intravag application daily, starting after documented ovulation or arbitrarily on day 18-21 of the cycle. When used during IVF Daily application should be continued for 30 days if there is laboratory evidence of pregnancy.
Contraindications
Hypersensitivity. Undiagnosed vag bleeding, known or suspected progesterone-sensitive malignant tumors, porphyria. Lactation.
Special Precautions
Breakthrough bleeding as in all cases of irregular vag bleeding, nonfunction causes should be considered. In cases of undiagnosed vag bleeding, adequate diagnostic measures should be taken. Discontinue treatment on missed abortion. Increased risk for thromboembolism. Severe hepatic insufficiency. Vag irritation. May affect ability to drive or operate machinery. Pregnancy (after 1st trimester). Lactation.
Adverse Reactions
Hypersensitivity eg, rash. Mild application site reaction. Headache, somnolence, breast tenderness, vag irritation, itching or burning, intermenstrual bleeding (spotting).
Drug Interactions
Not to be used concurrently w/ other local vag prep.
ATC Classification
G03DA04 - progesterone ; Belongs to the class of pregnen (4) derivative progestogens.
Presentation/Packing
Form
Crinone vag gel 8%/1.125 g
Packing/Price
1.13 g x 15 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in